Higher tumour incidence and maintenance of CSC or metabolic adaptation in hypoxic conditions were reported, suggesting that hypoxia may act as a major driver of resistance [243,244,245], with potential differential effects related to HIF-1α [246] and HIF-2 [247]. This evidence concerns the gene HIF1A and neoplasm.